Original Publication Date: 1 November, 2016
Publication / Source: International Journal of Endocrine Oncology
Authors: Zahra Nozhat, Mehdi Hedayati & Hoda Pourhassan
Medullary thyroid cancer (MTC) is the third most frequent thyroid cancer arising from thyroid parafollicular cells. Surgery is the first-line strategy in treatment of MTC but disease relapse and patient’s death have been observed in approximately two out of three of MTC cases. Identification of molecular mechanisms and different signaling pathways has offered new insights for disease treatment.